AGREEMENT RELATING TO THE PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK AND SECURITIES PURCHASE AGREEMENTPre-Funded Warrant and Securities Purchase Agreement • January 23rd, 2024 • Inhibrx, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 23rd, 2024 Company IndustryTHIS AGREEMENT (the “Agreement”), dated as of January 22, 2024, amends the Pre-Funded Warrant to Purchase Common Stock, dated August 31, 2023, issued by Inhibrx, Inc., a Delaware corporation (the “Company”), to [●] (the “Holder”) and specifies certain registration and other rights of the Holder.